cocaine has been researched along with lorazepam in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.17) | 18.7374 |
| 1990's | 5 (20.83) | 18.2507 |
| 2000's | 14 (58.33) | 29.6817 |
| 2010's | 2 (8.33) | 24.3611 |
| 2020's | 2 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Duffy, EM; Jorgensen, WL | 1 |
| Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
| Abraham, MH; Acree, WE; Ibrahim, A | 1 |
| Artursson, P; Bergström, CA; Draheim, R; Holmén, AG; Wassvik, CM | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Junien, JL; Wettstein, JG | 1 |
| Alexander, W; Bross, MH | 1 |
| Pike, RF | 1 |
| Beck, O; Lafolie, P | 1 |
| Ator, NA; Griffiths, RR; Sannerud, CA | 1 |
| Alexoff, DL; Brodie, JD; Chaurasia, CS; Chen, CE; Clarkson, FA; Dewey, SL; Fowler, JS; Porter, SP; Russo, NB; Straughter-Moore, RM; Tedeschi, D; Volkow, ND | 1 |
| Baudry, F; Douceron, H; Hassnaoui, S; Marc, B; Vaquero, P; Zerrouki, L | 1 |
| Honderick, T; Seaberg, D; Wears, R; Williams, D | 1 |
| Gerak, LR; Moerschbaecher, JM; Quinton, MS; Winsauer, PJ | 1 |
| Hartfield, D; Rezvani, M | 1 |
| Buchheimer, N; Calhoun, TL; Ehrenkaufer, R; Gage, HD; Mach, RH; Morgan, D; Nader, MA; Nader, SH | 1 |
| Bryant, SM; Kalimullah, EA | 1 |
| Anerella, C; Dakwar, E; Hart, CL; Levin, FR; Mathew, SJ; Nunes, EV | 1 |
| Arnold, TC; Horowitz, BZ; Lange, RA; Richards, JR | 1 |
| Sisco, E; Watt, L | 1 |
| Coulter, C; Garnier, M; Moore, C | 1 |
2 trial(s) available for cocaine and lorazepam
| Article | Year |
|---|---|
A prospective, randomized, controlled trial of benzodiazepines and nitroglycerine or nitroglycerine alone in the treatment of cocaine-associated acute coronary syndromes.
Topics: Acute Disease; Adult; Angina Pectoris; Anti-Anxiety Agents; Cocaine; Drug Therapy, Combination; Female; Humans; Lorazepam; Male; Nitroglycerin; Prospective Studies; Single-Blind Method; Syndrome; Time Factors; Vasoconstrictor Agents | 2003 |
Therapeutic infusions of ketamine: do the psychoactive effects matter?
Topics: Adult; Anesthetics, Dissociative; Cocaine-Related Disorders; Crack Cocaine; Cues; Data Interpretation, Statistical; Diagnostic and Statistical Manual of Mental Disorders; Dissociative Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Infusions, Intravenous; Inpatients; Ketamine; Lorazepam; Male; Motivation; Mysticism | 2014 |
22 other study(ies) available for cocaine and lorazepam
| Article | Year |
|---|---|
Prediction of drug solubility from Monte Carlo simulations.
Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Molecular characteristics for solid-state limited solubility.
Topics: Chemical Phenomena; Chemistry, Physical; Molecular Structure; Multivariate Analysis; Pharmaceutical Preparations; Regression Analysis; Solubility | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Effects of 5-HT3 antagonists on fixed-interval behavior in rats.
Topics: Animals; Behavior, Animal; Caffeine; Cocaine; Drug Interactions; Lorazepam; Male; Rats; Rats, Inbred Strains; Serotonin Antagonists | 1992 |
Cocaine intoxication in a 12 month-old.
Topics: Akathisia, Drug-Induced; Cocaine; Fluid Therapy; Humans; Infant; Lorazepam; Male; Poisoning; Psychomotor Agitation | 1991 |
Cocaine withdrawal. An effective three-drug regimen.
Topics: Amantadine; Cocaine; Humans; Lorazepam; Substance Withdrawal Syndrome; Substance-Related Disorders; Tryptophan | 1989 |
Deficient performance of drugs of abuse testing in Sweden: an external control study.
Topics: Amphetamines; Cannabinoids; Cocaine; Ephedrine; False Positive Reactions; Gas Chromatography-Mass Spectrometry; Humans; Lorazepam; Narcotics; Substance Abuse Detection; Sweden | 1994 |
Behavioral pharmacology of tandospirone in baboons: chronic administration and withdrawal, self-injection and drug discrimination.
Topics: Animals; Anti-Anxiety Agents; Arousal; Buspirone; Cocaine; Discrimination Learning; Dose-Response Relationship, Drug; Eating; Flumazenil; Isoindoles; Lorazepam; Male; Motor Skills; Neurologic Examination; Papio; Pentobarbital; Piperazines; Pyrimidines; Reinforcement Schedule; Self Administration; Serotonin Receptor Agonists; Substance Withdrawal Syndrome; Substance-Related Disorders | 1993 |
GABAergic attenuation of cocaine-induced dopamine release and locomotor activity.
Topics: 4-Aminobutyrate Transaminase; Animals; Cocaine; Corpus Striatum; Dopamine; Enzyme Inhibitors; Ethanol; GABA Modulators; gamma-Aminobutyric Acid; Lorazepam; Male; Microdialysis; Motor Activity; Rats; Rats, Sprague-Dawley; Time Factors; Vigabatrin | 1997 |
Sexual assault under benzodiazepine submission in a Paris suburb.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Benzodiazepines; Cocaine; Dronabinol; Estazolam; Female; Flunitrazepam; Humans; Hypnotics and Sedatives; Immunoassay; Lorazepam; Male; Morphine; Narcotics; Nitrazepam; Paris; Rape; Retrospective Studies; Substance-Related Disorders; Temazepam; Time Factors; Triazolam | 2000 |
Interaction of cocaine with positive GABAA modulators on the repeated acquisition and performance of response sequences in rats.
Topics: Anesthetics, Local; Animals; Cocaine; Dose-Response Relationship, Drug; Drug Interactions; Female; GABA Modulators; Learning; Lorazepam; Pregnanolone; Rats; Rats, Long-Evans; Task Performance and Analysis; Time Factors | 2005 |
Cocaine toxicity after laryngoscopy in an infant.
Topics: Administration, Topical; Anesthetics, Local; Cocaine; Humans; Hypertension; Infant; Laryngoscopy; Lorazepam; Male; Tachycardia | 2006 |
PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys.
Topics: Animals; Behavior, Addictive; Behavior, Animal; Brain; Cocaine; Food; GABA Modulators; Humans; Lorazepam; Macaca mulatta; Male; Positron-Emission Tomography; Receptors, Dopamine D2; Reinforcement, Psychology; Self Administration; Time Factors | 2006 |
Case files of the medical toxicology fellowship at the toxikon consortium in Chicago: cocaine-associated wide-complex dysrhythmias and cardiac arrest - treatment nuances and controversies.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anticonvulsants; Antidotes; Arrhythmias, Cardiac; Charcoal; Cocaine; Electrocardiography; Emergency Medical Services; Female; Heart Arrest; Humans; Lidocaine; Lorazepam; Pulse; Seizures; Sodium Bicarbonate; Sympathomimetics; Tachycardia, Ventricular; Young Adult | 2008 |
Dual cocaine and methamphetamine cardiovascular toxicity: rapid resolution with labetalol.
Topics: Administration, Intravenous; Adrenergic beta-Antagonists; Amphetamine-Related Disorders; Anti-Anxiety Agents; Anxiety; Cardiovascular Diseases; Cardiovascular System; Central Nervous System Stimulants; Chest Pain; Cocaine; Cocaine-Related Disorders; Drug Interactions; Electrocardiography; Humans; Hyperhidrosis; Labetalol; Lorazepam; Male; Methamphetamine; Sodium Chloride; Tachycardia; Young Adult | 2017 |
Detection of trace drugs of abuse in baby formula using solid-phase microextraction direct analysis in real-time mass spectrometry (SPME-DART-MS).
Topics: Cocaine; Dextromethorphan; Fentanyl; Food Contamination; Forensic Toxicology; Heroin; Humans; Illicit Drugs; Infant; Infant Formula; Lorazepam; Mass Spectrometry; Solid Phase Microextraction | 2021 |
Rapid Extraction and Qualitative Screening of 30 Drugs in Oral Fluid at Concentrations Recommended for the Investigation of DUID Cases.
Topics: 2-Propanol; 3,4-Methylenedioxyamphetamine; Alprazolam; Amphetamines; Buprenorphine; Carisoprodol; Clonazepam; Cocaine; Codeine; Dronabinol; Fentanyl; Hexanes; Hydrocodone; Hydromorphone; Lorazepam; Meprobamate; Methadone; Methamphetamine; Morphine Derivatives; N-Methyl-3,4-methylenedioxyamphetamine; Nordazepam; Oxazepam; Oxycodone; Oxymorphone; Pharmaceutical Preparations; Phencyclidine; Tandem Mass Spectrometry; Temazepam; Tramadol; Zolpidem | 2022 |